Hamid Hoveyda
Corporate Officer/Principal bij Ogeda SA
Profiel
Hamid Hoveyda is currently the Director-Medical Chemistry at Ogeda SA since 2007.
Previously, he worked as a Principal at Affymax, Inc. and Tranzyme Pharma, Inc. (Canada).
Dr. Hoveyda holds a doctorate degree from the University of British Columbia.
Actieve functies van Hamid Hoveyda
| Bedrijven | Functie | Begin |
|---|---|---|
Ogeda SA
 Ogeda SA Pharmaceuticals: MajorHealth Technology Ogeda SA discovers and develops small molecule drugs. It develops NK3 antagonists for the treatment of hormone-dependent pathologies in the field of Women's Health. The company was founded in 1994 and is headquartered in Gosselies, Spain. | Corporate Officer/Principal | 01-09-2007 |
Eerdere bekende functies van Hamid Hoveyda
| Bedrijven | Functie | Einde |
|---|---|---|
| Tranzyme Pharma, Inc. (Canada) | Corporate Officer/Principal | - |
| AFFYMAX, INC. | Corporate Officer/Principal | - |
Opleiding van Hamid Hoveyda
| University of British Columbia | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| AFFYMAX, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Ogeda SA
Ogeda SA Pharmaceuticals: MajorHealth Technology Ogeda SA discovers and develops small molecule drugs. It develops NK3 antagonists for the treatment of hormone-dependent pathologies in the field of Women's Health. The company was founded in 1994 and is headquartered in Gosselies, Spain. | Health Technology |
| Tranzyme Pharma, Inc. (Canada) |